Table 1.
Dialysis | Ulcer history | Total | |
---|---|---|---|
n | 150 | 150 | 300 |
Male (%) | 61 (40.7) | 62 (41.3) | 123 (41.0) |
Race* | |||
White | 116 (77.3) | 64 (42.7) | 180 (60.0) |
Black | 20 (13.3) | 54 (36.0) | 74 (24.7) |
Hispanic | 11 (7.3) | 28 (18.6) | 39 (13.0) |
Other | 3 (2.0) | 4 (2.7) | 7 (2.3) |
Age* | 64.9 ± 0.98 | 74.25 ± 1.04 | 70.22 ± 0.58 |
Type 2 diabetes (%) | 139 (92.6) | 138 (92.0) | 277 (92.3) |
Amputation (%)* | 22 (14.7) | 5 (3.3) | 27 (9) |
Ulceration (%) | 79 (52.7) | 79 (52.7) | 158 (52.6) |
Neuropathy testing | |||
Semmes Weinstein monofilament | 40 (26.7) | 41 (27.3) | 81 (27) |
Vibration perception threshold | 4 (2.7) | 3 (2.0) | 7 (2.3) |
Other assessment | 5 (3.3) | 12 (8.0) | 17 (5.7) |
No neuropathy testing | 101 (67.3) | 94 (62.7) | 195 (65) |
Vascular assessment | |||
Pedal pulse evaluated | 71 (47.3) | 84 (56.0) | 155 (51.7) |
Ankle-brachial index evaluated | 19 (12.7) | 13 (8.7) | 32 (10.7) |
No assessment | 60 (40.0) | 53 (35.3) | 113 (37.6) |
Diabetes education | |||
Session 1 (n) | 1 (0.6) | 0 | 1 (0.3) |
Session 2 (n) | 1 (0.6) | 0 | 1 (0.3) |
Sessions 3–4 | 0 | 0 | 0 |
Podiatry | |||
Podiatry (anytime)* | 74 (49.3) | 121 (80.6) | 195 (65) |
Podiatry before an ulcer* | 63 (42) | 27 (18) | 90 (30) |
Total podiatry visits | 296 | 362 | 658 |
Therapeutic shoes and insoles | |||
Received shoes or insoles | 11 (7.3) | 10 (6.6) | 21 (7.0) |
Received second shoes or insoles | 1 (0.6) | 3 (2.0) | 4 (1.3) |
Received third shoes or insoles | 0 | 0 | 0 |
Data are n (%) or means ± SE.
*P < 0.001.